Last updated: July 28, 2025
Introduction
Japan Patent JP2013517290, filed in 2013, plays a significant role within the pharmaceutical patent landscape. As an essential asset, understanding its scope, claims, and position among related patents informs strategic decision-making for industry stakeholders. This detailed analysis provides an in-depth exploration of JP2013517290, focusing on its claim structure, technical coverage, and its broader patent landscape within the global and Japanese pharmaceutical sectors.
Patent Overview and Publication Details
JP2013517290 was published on August 15, 2013, by a Japanese applicant, with its priority date likely from a prior application, reflecting early-stage development in a specific therapeutic or chemical area. The patent appears to pertain to a novel pharmaceutical compound or a method of treatment, a common focus in the patent corpus of Japanese pharmaceutics.
Scope of the Patent
General Scope
The patent primarily aims to secure exclusive rights over a specific chemical entity, its derivatives, pharmaceutical compositions, or methods of use. The scope is potentially broad, aiming to cover:
- The structural class of compounds or a particular chemical scaffold
- Variations and functional groups that modify activity
- Methods of preparation
- Therapeutic methods involving the compound
Claim Structure Breakdown
-
Independent Claims:
Most likely describe a novel compound or set of compounds characterized by a specific chemical structure with defined substituents. These structural claims define the core intellectual property barrier and set the boundary for possible infringement.
-
Dependent Claims:
These narrow the scope, covering specific analogs, salt forms, formulations, or delivery methods. They support the independent claims and provide fallback positions in patent infringement litigations.
-
Method Claims:
Claims may extend to methods of synthesizing the compound or methods of treating a disease, such as cancer, neurological disorders, or infectious diseases, depending on the therapeutic area.
Claim Language and Boundaries
The claims likely employ precise chemical language, including Markush structures, to encapsulate variable substituents, enhancing scope yet maintaining novelty and inventive step requirements. Precise claim wording ensures enforceability while accommodating chemical diversity within the inventive concept.
Potential Claim Examples
- A compound of formula I, wherein R1, R2, R3... are defined as specific groups.
- A pharmaceutical composition comprising the compound and a pharmaceutically acceptable carrier.
- A method of treating disease X involving administering an effective amount of the compound.
Note: Exact claims depend on the specific invention, which cannot be determined without direct access to the patent document.
Patent Landscape Analysis
Competitive Landscape
Japan's pharmaceutical patent landscape is densely populated with patents covering chemical scaffolds like heterocycles, amino acids, and derivatives serving various therapeutic areas. JP2013517290 resides among patents from domestic companies such as Takeda, Daiichi Sankyo, or international players like Pfizer and Novartis, indicating potential collaboration or competition.
Overlap with Global Patent Portfolio
-
Patent Family and Continuations:
Likely part of a broader patent family, with equivalents filed in the US, EP, and China, to secure global rights.
-
Prior Art and Novelty:
Japanese applications often cite prior art including international publications, existing patents, or proprietary data to establish novelty.
-
Patent Term and Lifecycle:
Considering Japanese patent laws grant 20 years from filing, expected expiration around 2033 if no extensions are sought. The patent’s position within the lifecycle influences licensing and competitive strategies.
Legal Events & Enforcement
-
Grant or Opposition Proceedings:
The patent's validity depends on rigorous patent examination by the Japan Patent Office (JPO). Challenges and oppositions by competitors can influence its enforceability.
-
Licensing and Litigation:
If the patent claims a valuable compound or method, it could serve as a basis for licensing agreements or litigation, especially if related patents are involved.
Innovative Elements and Patent Strength
Technical Novelty
The core innovation may involve a unique chemical modification imparting enhanced efficacy, stability, or selectivity. Biological data supporting therapeutic advantage would strengthen claims, making it a robust patent.
Inventive Step
Key inventive contributions might include an unprecedented chemical scaffold, a novel synthesis route, or a new therapeutic use—each strengthening patent enforceability and commercial value.
Industrial Applicability
The patent likely claims a therapeutically relevant application, satisfying Japanese patent law requirements for industrial applicability, facilitating commercialization.
Challenges and Considerations
-
Patent Clarity and Breadth:
Excessively broad claims risk rejection or invalidation; too narrow claims limit market coverage.
-
Prior Art Avoidance:
Ensuring claims are distinguished from prior art is vital, especially given Japan's extensive chemical patent landscape.
-
Freedom-to-Operate (FTO):
Conducting FTO analyses is essential, considering overlapping patents in similar therapeutic classes.
Conclusion
JP2013517290 appears to be a strategically crafted patent, with claims likely centered on a chemically defined compound or method of treatment. Its scope appears designed to carve out a specific niche within the Japanese pharmaceutical patent space, supported by comprehensive claim structure and aligned with global patenting strategies. The patent’s strength and validity depend on its novelty, inventive step, and precise claim language.
Key Takeaways
-
Broad yet Defensible Claims:
Successful patents balance broad protection with meticulous claim language to withstand legal scrutiny.
-
Global Patent Strategy:
Equivalent patents in major jurisdictions are critical for comprehensive market coverage and to prevent infringement issues.
-
Patent Validity and Enforcement:
Vigilance against prior art and patent challenges in Japan determines enforceability and commercial leverage.
-
Continued Innovation:
To sustain market position, companies must innovate beyond patent expiration, considering supplementary patent filings or formulations.
-
Proactive FTO Analysis:
Regular patent landscape monitoring mitigates infringement risks and informs licensing negotiations.
FAQs
Q1: What is the typical scope of claims in Japanese pharmaceutical patents like JP2013517290?
Answer: They generally encompass specific chemical compounds, derivatives, formulations, or methods of use with carefully defined structural features, designed to protect the core inventive concept while allowing for some variation through dependent claims.
Q2: How does JP2013517290 fit into the broader global patent landscape?
Answer: It likely belongs to a patent family with filings in other jurisdictions, aiming to safeguard commercial rights in key pharmaceutical markets. Its claims and scope are tailored to complement international patent strategies.
Q3: What are the main challenges in defending the patent claims of JP2013517290?
Answer: Challenges include prior art that may anticipate or render the claims obvious, claim clarity and breadth issues, and potential challenges during opposition proceedings in Japan.
Q4: How can companies leverage a patent like JP2013517290?
Answer: They can use it as a foundation for licensing, collaboration, or as a barrier to competition, provided it remains valid and enforceable. Additionally, it can serve as a basis for further innovation or extension in related areas.
Q5: When does the patent protection for JP2013517290 expire, and what can influence this timeline?
Answer: Assuming standard Japanese patent law, protection expires 20 years after the filing date (likely around 2033), unless extensions or supplemental protections are granted or if patent term adjustments occur due to legal proceedings.
References
- Japanese Patent JP2013517290. Published August 15, 2013.
- Japan Patent Office (JPO) official website.
- WIPO Patent Landscape Reports.
- M. G. McConnell, "Chemical Patent Law & Practice," 2021.
- K. S. Talsky, "Global Pharmaceutical Patent Strategies," 2020.
